Loading...
Interpreting Biomarker Results in Individual Patients With Mild Cognitive Impairment in the Alzheimer’s Biomarkers in Daily Practice (ABIDE) Project
IMPORTANCE: Biomarkers do not determine conversion to Alzheimer disease (AD) perfectly, and criteria do not specify how to take patient characteristics into account. Consequently, biomarker use may be challenging for clinicians, especially in patients with mild cognitive impairment (MCI). OBJECTIVE:...
Na minha lista:
| Udgivet i: | JAMA Neurol |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Medical Association
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5822193/ https://ncbi.nlm.nih.gov/pubmed/29049480 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaneurol.2017.2712 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|